Target intelligence / Profile preview

Oral Gram-negative anaerobic bacteria and mixed oral biofilm communities

Molecular classification
Other
01

Overview

Oral Gram-negative anaerobic bacteria and mixed oral biofilm communities are complex polymicrobial assemblies that colonize the oral cavity, particularly the subgingival environment. These communities are the primary etiological agents of periodontal diseases, including gingivitis and periodontitis, where a shift from aerobic to anaerobic species leads to chronic inflammation and tissue destruction [PMID: 15355360]. Key pathogens within these biofilms, such as Porphyromonas gingivalis and Treponema denticola, employ sophisticated mechanisms like quorum sensing and metabolic cross-feeding to survive and evade the host immune system [PMID: 15125628]. Therapeutic intervention focuses on the mechanical disruption of the biofilm and the use of antimicrobial agents to reduce the load of pathogenic species. However, the protective nature of the biofilm matrix makes these communities significantly more resistant to antibiotics compared to planktonic cells, posing a major challenge in clinical management [PMID: 21762155]. Effective treatment often requires a combination of physical debridement and targeted chemotherapy to restore a healthy microbial balance.

Other names
Dental plaqueSubgingival biofilmPeriodontal pathogensOral microbiotaRed complex bacteriaDental biofilm
02

Mechanism of action

Antimicrobials targeting these communities typically act by inhibiting bacterial cell wall synthesis (e.g., beta-lactams), disrupting protein synthesis (e.g., tetracyclines), or interfering with DNA replication (e.g., metronidazole) [PMID: 15355360]. Additionally, antiseptic agents like chlorhexidine disrupt the bacterial cell membrane and prevent biofilm attachment [PMID: 28203155].

03

Biological functions

Biofilm formationQuorum sensingAnaerobic metabolismHost immune evasionInterspecies signalingMetabolic cooperation
04

Disease associations

InfectionInflammationPeriodontitisGingivitisEndodontic infectionDental caries
05

Safety considerations

Development of antimicrobial resistanceDisruption of the commensal oral microbiome (dysbiosis)Systemic side effects of antibioticsPotential for opportunistic infections like oral candidiasisStaining of teeth or restorations associated with chlorhexidine use
06

Interacting drugs

Metronidazole

6 more in the full profile.

07

Biomarkers

Probing pocket depth (PPD)Clinical attachment loss (CAL)Bleeding on probing (BOP)Levels of Porphyromonas gingivalis in subgingival plaqueGingival crevicular fluid (GCF) cytokine levels

Beyond the preview

Go deeper on Oral Gram-negative anaerobic bacteria and mixed oral biofilm communities.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral Gram-negative anaerobic bacteria and mixed oral biofilm communities.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call